Hartland & Co »

Acumen Pharmaceuticals shares owned by Hartland & Co

Quarter-by-quarter ownership of Acumen Pharmaceuticals (ABOS) shares owned by Hartland & Co from 13F filings

Historical chart of Hartland & Co investment in Acumen Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acumen Pharmaceuticals held by Hartland & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acumen Pharmaceuticals by Hartland & Co

Quarter filed Position value Share count Share price at filing
2025-12-31 $127 60 2.12
2025-06-30 $73 63 1.17

More positions owned by Hartland & Co

Vanguard Index Fds Put Put Option (Principal) (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Apple Put Put Option (Principal) (AAPL)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Index Fds Mid Cap Etf (VO)
Microsoft Corporation (MSFT)
Vanguard Index Fds Small Cp Etf (VB)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Vanguard Index Fds Value Etf (VTV)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Nvidia Corporation Put Put Option (Principal) (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Spdr S&p 500 Etf Tr Tr Unit (SPY)

View all positions for Hartland & Co

Top funds holding Acumen Pharmaceuticals

RA Capital Management
Sands Capital Ventures
Franklin Resources
FMR
Vanguard Group
Knollwood Investment Advisory
Alyeska Investment Group
ADAR1 Capital Management
Laurion Capital Management
Pathstone Holdings
Hudson Bay Capital Management
Millennium Management
Citadel Advisors
Two Sigma Advisers
Renaissance Technologies

View all funds holding Acumen Pharmaceuticals